Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, announced today that it has signed an agreement to acquire NeedleTech Products, Inc., Attleboro, MA, a privately held manufacturer of specialty needles and related medical devices, for $47.8 million in cash, subject to adjustment. The acquisition is expected to close in the third quarter of 2008.

Genesis Capital was the Company's financial advisor, and Powell Goldstein LLP was the Company's legal advisor on this transaction.